menu
    • menu
    [{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Fonterra Co-operative Group","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Probiotic","year":"2023","type":"Partnership","leadProduct":"Akkermansia Muciniphila","moa":"||Undisclosed","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Pendulum Therapeutics","amount2":0.01,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0.01,"dosageForm":"Capsule","sponsorNew":"Pendulum Therapeutics \/ Fonterra Co-operative Group","highestDevelopmentStatusID":"15","companyTruncated":"Pendulum Therapeutics \/ Fonterra Co-operative Group"},{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"U.S.A","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Akkermansia Muciniphila","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase I","graph3":"Pendulum Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pendulum Therapeutics \/ Pendulum Therapeutics","highestDevelopmentStatusID":"6","companyTruncated":"Pendulum Therapeutics \/ Pendulum Therapeutics"},{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Pendulum Glucose","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Pendulum Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pendulum Therapeutics \/ Pendulum Therapeutics","highestDevelopmentStatusID":"1","companyTruncated":"Pendulum Therapeutics \/ Pendulum Therapeutics"},{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Synbiotic","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Pendulum Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pendulum Therapeutics \/ Pendulum Therapeutics","highestDevelopmentStatusID":"1","companyTruncated":"Pendulum Therapeutics \/ Pendulum Therapeutics"},{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Eden Miller","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"WBF-0031","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Pendulum Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pendulum Therapeutics \/ Eden Miller","highestDevelopmentStatusID":"1","companyTruncated":"Pendulum Therapeutics \/ Eden Miller"},{"orgOrder":0,"company":"Pendulum Therapeutics","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"U.S.A","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"WBF-038","moa":"Undisclosed","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase I","graph3":"Pendulum Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Pendulum Therapeutics \/ Pendulum Therapeutics","highestDevelopmentStatusID":"6","companyTruncated":"Pendulum Therapeutics \/ Pendulum Therapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by Pendulum Therapeutics

    Menu

    Pendulum Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : WBF-038

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Study Phase : Phase I

                            Recipient : University of Cincinnati

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

                            Details : WBF-038 is a Probiotic drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Radiation Injuries.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            November 17, 2025

                            Lead Product(s) : WBF-038

                            Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                            Highest Development Status : Phase I

                            Recipient : University of Cincinnati

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Akkermansia Muciniphila

                            Therapeutic Area : Dermatology

                            Study Phase : Phase I

                            Recipient : Medical University of South Carolina

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Role of Akkermansia Muciniphila in Acne Vulgaris

                            Details : Akkermansia Muciniphila is a Other Large Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Acne Vulgaris.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            May 28, 2025

                            Lead Product(s) : Akkermansia Muciniphila

                            Therapeutic Area : Dermatology

                            Highest Development Status : Phase I

                            Recipient : Medical University of South Carolina

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Synbiotic

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Undisclosed

                            Recipient : Texas Christian University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Next-Generation Synbiotic in Individuals With Overweight or Obesity

                            Details : Synbiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            January 19, 2024

                            Lead Product(s) : Synbiotic

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Undisclosed

                            Recipient : Texas Christian University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Akkermansia Muciniphila,Chicory Inulin

                            Therapeutic Area : Gastroenterology

                            Study Phase : Approved FDF

                            Sponsor : Fonterra Co-operative Group

                            Deal Size : $10.0 million

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Global Nutrition Science Leader...

                            Details : The partnership aims to co-develop and commercialize next-generation microbiome products including, Akkermansia muciniphila, a mucin-degrading bacterium commonly found in human gut.

                            Product Name : Akkermansia

                            Product Type : Probiotic

                            Upfront Cash : Undisclosed

                            June 27, 2023

                            Lead Product(s) : Akkermansia Muciniphila,Chicory Inulin

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Approved FDF

                            Sponsor : Fonterra Co-operative Group

                            Deal Size : $10.0 million

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : WBF-0031

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Eden Miller

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose Tolerance

                            Details : WBF-0031 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Glucose Intolerance.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            July 29, 2020

                            Lead Product(s) : WBF-0031

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Eden Miller

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed

                            Pendulum Therapeutics

                            U.S.A arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Pendulum Glucose

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : University of Southern California

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pendulum D2D Glucose Control for Adults With Type 2 Diabetes

                            Details : Pendulum Glucose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            January 14, 2020

                            Lead Product(s) : Pendulum Glucose

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : University of Southern California

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth